Richard godfrey

Biography

 Mr. Richard S. Godfrey has served as Chief Executive Officer (CEO) of Bergenbio ASA since 2008. He has more than 28 years’ industry experience leading many international drug development and commercialization partnerships. Formerly he served as Chief Executive Officer of Aenova Inc., a specialist biopharmaceutical company. Prior to this he was the Managing Director of DCC Healthcare Ltd and previously he held positions of increasing responsibility at Catalant, Eli Lilly and Reckitt Benckiser in R&D and commercial roles. He qualified as a Pharmacist from Liverpool University and received his M.B.A. from Bath University. He serves at Square One Holding AS (board member), Gnist Holding AS (managing director and chairman), Magnet Strategy and marketing Partners AS (board member), Biotec Pharmacon ASA (board member), Balter Medical AS (board member), Uni Targeting Research AS (chairman), Petosan AS (chairman) and Gnist Ltd (director). He was previously employed at Sarisa Venture management (board member and partner), Ayanda Group AS (board member) and Captech AS (board member).

Research Interest

 Pharmaceutical